Abstract
Most people around the world are infected with Helicobacter pylori (H.pylori); it can lead to duodenal ulcer (DU) and gastric cancer (GC). The main objective of this study is to determine the correlation between CD14 and CD163 in individuals with DU and GC infected with H.pylori. Sixty nine individuals were included in this work; 27 patients infected with H.pylori only (H.Pylori+), 22 patients infected with H.pylori with DU and 20 patients infected with H.pylori with GC. CD14 and CD163 were measured in all individuals' serum using the Enzyme-Linked Immunoassay (ELISA) test. The results proved there was negative correlation between CD14 and CD163 in H.pylori-positive patients (y= -0.0263x+1.4179). While, there was positive correlation in H.pylori-positive patients with DU (y= 0.0932x+1.6647) and with GC (y= 0.0607x + 1.9824). In conclusion: CD14 and CD163 have a synergistic protected effect in H.pylori-positive patients with DU and GC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
